PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsVariant angina pectoris
MeSH D000788 - variant angina pectoris
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D000789:Unstable angina
$
Success rate
D000788: 
Variant angina pectoris
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaDiltiazem Diltiazem  1992-11-05   
Verapamil Verapamil  1992-07-31   
Novast LaboratoriesDiltiazem Diltiazem  2019-06-14   
Glenmark PharmaceuticalsDiltiazem Diltiazem  2021-03-22   
Verapamil, Trandolapril Trandolapril Verapamil  2010-05-05   
Verapamil Verapamil  2009-09-17   
MylanAtorvastatin, Amlodipine besylate Amlodipine Besylate Atorvastatin  2013-11-29   
Diltiazem Diltiazem  1997-05-02   
Verapamil Verapamil  1999-04-20   
SandozDiltiazem Diltiazem  2012-09-28   
1
2
3
4
5
6
...
11
>
Clinical Trials
Historical Success Rate
Phase 1
0%
0/0
Phase 2
0%
0/0
Phase 3
100%
9/9
Approved: 9Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
1
2
3
4
5
6
7
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use